BR112014013374A2 - formulações de acamprosato, métodos de usar o mesmo, e as combinações que compõem o mesmo - Google Patents

formulações de acamprosato, métodos de usar o mesmo, e as combinações que compõem o mesmo Download PDF

Info

Publication number
BR112014013374A2
BR112014013374A2 BR112014013374A BR112014013374A BR112014013374A2 BR 112014013374 A2 BR112014013374 A2 BR 112014013374A2 BR 112014013374 A BR112014013374 A BR 112014013374A BR 112014013374 A BR112014013374 A BR 112014013374A BR 112014013374 A2 BR112014013374 A2 BR 112014013374A2
Authority
BR
Brazil
Prior art keywords
methods
formulations
same
combinations
make
Prior art date
Application number
BR112014013374A
Other languages
English (en)
Other versions
BR112014013374B1 (pt
BR112014013374A8 (pt
Inventor
S Fogel Barry
Fong Kei-Lai
D Kerns William
Original Assignee
Synchroneuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synchroneuron Inc filed Critical Synchroneuron Inc
Publication of BR112014013374A2 publication Critical patent/BR112014013374A2/pt
Publication of BR112014013374A8 publication Critical patent/BR112014013374A8/pt
Publication of BR112014013374B1 publication Critical patent/BR112014013374B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo “formulações de acamprosato, métodos de usar o mesmo, e as combinações que compõem o mesmo” formas de realização aqui divulgadas estão geralmente associados às formulações de acamprosato, métodos de utilização das formulações, a métodos de utilização das formulações em combinação com pelo menos um outro medicamento, e para produtos de combinação e as composições que compreendem as formulações e pelo menos um outro medicamento, tal como neurolépticos (antipsicótico) e/ou medicamentos antidepressivos.
BR112014013374-3A 2011-12-02 2012-12-02 Comprimidos de acamprosato e usos de acamprosato referência cruzada aos pedidos relacionados BR112014013374B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161566550P 2011-12-02 2011-12-02
US61/566,550 2011-12-02
US201261649137P 2012-05-18 2012-05-18
US61/649,137 2012-05-18
PCT/US2012/067507 WO2013082573A1 (en) 2011-12-02 2012-12-02 Acamprosate formulations, methods of using the same, and combinations comprising the same

Publications (3)

Publication Number Publication Date
BR112014013374A2 true BR112014013374A2 (pt) 2017-06-13
BR112014013374A8 BR112014013374A8 (pt) 2021-08-31
BR112014013374B1 BR112014013374B1 (pt) 2022-10-11

Family

ID=48536156

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014013374-3A BR112014013374B1 (pt) 2011-12-02 2012-12-02 Comprimidos de acamprosato e usos de acamprosato referência cruzada aos pedidos relacionados

Country Status (14)

Country Link
EP (1) EP2785337B1 (pt)
JP (1) JP6407720B2 (pt)
KR (1) KR102055859B1 (pt)
CN (1) CN104379138B (pt)
AU (1) AU2012345659B2 (pt)
BR (1) BR112014013374B1 (pt)
CA (1) CA2863265C (pt)
HK (2) HK1199841A1 (pt)
IL (1) IL232935B (pt)
MX (1) MX2014006574A (pt)
RU (1) RU2671399C2 (pt)
SG (1) SG11201403785UA (pt)
WO (1) WO2013082573A1 (pt)
ZA (1) ZA201404826B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3003297A4 (en) * 2013-06-05 2017-04-19 Synchroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3946303A4 (en) * 2019-04-03 2022-12-14 Synchroneuron Inc. FORMULATING
CN114746950A (zh) * 2019-10-11 2022-07-12 豪夫迈·罗氏有限公司 药物剂量确定设备和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036064A2 (en) * 1998-01-13 1999-07-22 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
RU2284814C1 (ru) * 2005-04-08 2006-10-10 Государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства здравоохранения Российской Федерации" Способ лечения оптического неврита при оптикохиазмальном арахноидите в стадии ремиссии
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
MX2009006056A (es) * 2006-12-07 2009-06-16 Schering Corp Formulacion de matriz sensible al ph.
DE102007009242A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
ES2600894T3 (es) * 2010-02-22 2017-02-13 Daiichi Sankyo Company, Limited Preparación sólida de liberación sostenida para uso oral
CN101987081B (zh) * 2010-07-16 2012-08-08 钟术光 一种控释制剂
MX346203B (es) * 2010-09-28 2017-03-09 Depomed Inc Formas de dosificacion retentivas gastricas para liberacion prolongada de acamprosato en el tracto gastrointestinal superior.

Also Published As

Publication number Publication date
BR112014013374B1 (pt) 2022-10-11
AU2012345659B2 (en) 2017-09-28
AU2012345659A8 (en) 2014-08-07
KR102055859B1 (ko) 2019-12-13
MX2014006574A (es) 2015-02-10
EP2785337A1 (en) 2014-10-08
CA2863265A1 (en) 2013-06-06
BR112014013374A8 (pt) 2021-08-31
KR20140121394A (ko) 2014-10-15
ZA201404826B (en) 2016-07-27
CN104379138A (zh) 2015-02-25
EP2785337B1 (en) 2021-01-20
IL232935A0 (en) 2014-07-31
CN104379138B (zh) 2021-12-07
IL232935B (en) 2020-11-30
AU2012345659A1 (en) 2014-07-24
RU2014126879A (ru) 2016-01-27
RU2671399C2 (ru) 2018-10-31
HK1199841A1 (en) 2015-07-24
HK1207563A1 (en) 2016-02-05
SG11201403785UA (en) 2014-10-30
JP2015500812A (ja) 2015-01-08
EP2785337A4 (en) 2015-04-22
WO2013082573A1 (en) 2013-06-06
JP6407720B2 (ja) 2018-10-17
CA2863265C (en) 2020-04-14

Similar Documents

Publication Publication Date Title
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112017012434A2 (pt) composições de canabinóide microencapsuladas
MX2016008448A (es) Conjugados de var2csa-farmaco.
CL2015000331A1 (es) Compuestos derivados de piridazina 1,4-disustitutidos; composicion y combinacion farmaceutica que los comprende y uso en el tratamiento de la atrofia muscular espinal.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
PH12015501393A1 (en) Pesticidal compositions and processes related thereto
MY156951A (en) Micromirs
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
BR112013032717A2 (pt) coagonistas do receptor de glucagon/glp-1
BR112013001613A2 (pt) compostos tricíclicos e métodos para fazer e usar os mesmos.
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
BR112015013078A2 (pt) composição compreendendo uma resina de silicone e uma goma de silicone, produtos para cuidados pessoais contendo a mesma
MX2015008065A (es) Composiciones pesticidas y procesos relacionados con ellas.
BR112012019190A2 (pt) composições de cuidado oral.
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
BR112012019997A2 (pt) composições de cuidado oral
GT201700138A (es) Pirazolpiridinaminas
BR112015004515A2 (pt) composição imunogênica
BR112015001697A2 (pt) formulações de clomazona
BR112012019351A2 (pt) composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 31/185 , A61K 9/20 , A61K 9/48 , A61P 25/00

Ipc: A61K 31/185 (2006.01), A61K 45/06 (2006.01), A61K

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/12/2012, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2701 DE 11/10/2022, QUANTO AO ITEM (54) TITULO.